June 9, 2026

BPC-157 and TB-500 turn up constantly in tissue-repair and regeneration research, and they're often discussed together. They are not the same compound, and they don't share a mechanism. Treating them as interchangeable is a common error in study design and procurement.
This post breaks down what each peptide is, how they differ at the molecular level, and what to verify before purchasing. Everything below applies to research use only. These compounds are not for human consumption and are not approved for therapeutic use in Canada.
BPC-157 is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a partial sequence of a protein found in gastric juice. In literature it's frequently labeled a "body protection compound" fragment. It is investigated in models of connective tissue, gastrointestinal, and angiogenesis research.
Key structural points:
In research contexts, BPC-157 is studied for its proposed effects on the nitric oxide pathway and on factors associated with new blood vessel formation. These are mechanistic research observations, not established outcomes.
TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4 (TΞ²4), a naturally occurring 43-amino-acid protein involved in actin regulation. TB-500 typically refers to the active region of that larger protein rather than the full sequence.
Key structural points:
Because TB-500 is a fragment of a well-characterized endogenous protein, researchers should confirm exactly which sequence a supplier is providing. "TB-500" is a trade name, not a strict chemical identifier, so the certificate of analysis matters more than the label.
The two are easy to confuse because both appear in regeneration and tissue-repair research. They are mechanistically distinct.
These are different molecular targets. A study designed around one does not automatically translate to the other.
Both are commonly supplied as lyophilized powders. Solubility behavior differs by peptide and by batch, so reconstitution planning should be based on the specific lot, not general assumptions. Researchers often use a Peptide Calculator to standardize concentrations across experiments and keep records consistent between batches.
For either peptide, purity and identity verification are non-negotiable. The label tells you very little; the testing data tells you everything.
What to look for on a certificate of analysis:
A supplier that publishes batch-specific data is giving you something usable. A generic spec sheet that never changes between lots is a red flag.
Lyophilized peptides are more stable than reconstituted solutions, but neither is indefinitely stable.
General handling principles:
Keep storage conditions documented alongside your experimental records. Stability assumptions that aren't written down tend to get violated.
This is where most sourcing decisions should actually be made. A COA is only useful if you know how to interpret it.
If a supplier can't produce a batch-specific COA on request, that tells you what you need to know.
No. They are distinct peptides with different sequences, different origins, and different proposed mechanisms. BPC-157 is a 15-amino-acid sequence linked to a gastric protein; TB-500 is a fragment based on Thymosin Beta-4. They are often grouped together in regeneration research, but they are not interchangeable.
They can be sold and purchased for laboratory research use only. They are not approved as drugs or supplements in Canada, are not for human consumption, and carry no therapeutic approval. Buyers are responsible for compliance with applicable regulations governing research materials.
Research-grade peptides are commonly offered at 95%, 98%, or 99% HPLC purity. The right threshold depends on your application β€” more sensitive assays generally call for higher purity. Always confirm the purity is backed by a batch-specific HPLC chromatogram and mass spec data.
Some preclinical study designs investigate them together because they target different pathways. Whether that's appropriate depends entirely on the research question and protocol. This is a design decision for the investigator, not a usage recommendation, and nothing here should be read as one.
Lyophilized powder is typically stored frozen for long-term stability. Reconstituted solutions are less stable and have shorter usable windows. Avoid repeated freeze-thaw cycles and keep material protected from light and moisture. Always follow the storage guidance on the batch COA.
Peptide Depot supplies research peptides to Canadian labs with batch-specific testing documentation. Sourcing domestically reduces customs delays and shipping time at temperature, which matters for stability-sensitive material.
BPC-157 and TB-500 are different tools studied in overlapping research areas. The mechanisms don't line up, so your experimental design should treat them as separate compounds with separate controls. Whatever you choose, the quality of your data depends on the quality of your starting material. Verify purity by HPLC, confirm identity by mass spec, check water content, and insist on a batch-specific COA.
All products discussed here are for research use only and are not for human consumption.